Clinical Trial Update: Study of SC-102 in Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating SC-102 in patients with advanced solid tumors, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• SC-102

Snippet

Sponsor: Tianjin ConjuStar Biologics Co., Ltd. | Conditions: Advanced Solid Cancers | Phase 1 | Status: RECRUITING